FDA Clearance Tracker · P990028-S001
FOCALSEAL-L SYNTHETIC ABLSORBABLE SEALANT
Last checked: Nov 20, 2026Latest source record: Apr 20, 2001 (this decision)Source: openFDAMethods & limitations
Decided
Apr 20, 2001
Approved
Time to decision
266 days
Received Jul 28, 2000. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class II
The decision
- FDA number
- P990028-S001
- Device name
- FOCALSEAL-L SYNTHETIC ABLSORBABLE SEALANT
- Applicant
- Genzyme Corp.
- Applicant location
- Cambridge, MA
- Received
- Jul 28, 2000
- Decided
- Apr 20, 2001
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P990028
Device type
- Device type
- Mesh, surgical, polymeric (FTL)
- Device class
- Class II
- Regulation
- 21 CFR 878.3300
- Specialty
- General & Plastic Surgery
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE POST APPROVAL STUDY PROTOCOL PMS-0001-0.
Source documents
Other decisions for Genzyme Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.